ALG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.400420E-01
Normal-vs-Stage2
6.890600E-01
Normal-vs-Stage3
1.954810E-01
Normal-vs-Stage4
4.740000E-01
Stage1-vs-Stage2
1.462030E-01
Stage1-vs-Stage3
1.290270E-02
Stage1-vs-Stage4
5.846200E-01
Stage2-vs-Stage3
8.785700E-02
Stage2-vs-Stage4
5.838400E-01
Stage3-vs-Stage4
1.041620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.929800E-01
Normal-vs-AfricanAmerican
5.746600E-01
Normal-vs-Asian
3.602400E-01
Caucasian-vs-AfricanAmerican
9.526800E-01
Caucasian-vs-Asian
6.489600E-01
AfricanAmerican-vs-Asian
7.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.278800E-01
Normal-vs-Female
6.714200E-01
Male-vs-Female
3.518400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.719000E-01
Normal-vs-Age(41-60Yrs)
3.816000E-01
Normal-vs-Age(61-80Yrs)
7.696600E-01
Normal-vs-Age(81-100Yrs)
8.970400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.409000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.580200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.454600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.324200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.296400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.688200E-01
Normal-vs-Daily Drinker
8.050200E-01
Normal-vs-Weekly Drinker
6.142000E-01
Normal-vs-Occasional Drinker
1.926040E-01
Normal-vs-Social Drinker
4.836800E-01
Non Drinker-vs-Daily Drinker
2.988600E-01
Non Drinker-vs-Weekly Drinker
1.115590E-01
Non Drinker-vs-Occasional Drinker
1.509790E-01
Non Drinker-vs-Social Drinker
8.380100E-02
Daily Drinker-vs-Weekly Drinker
7.493800E-01
Daily Drinker-vs-Occasional Drinker
2.463600E-01
Daily Drinker-vs-Social Drinker
2.251200E-01
Weekly Drinker-vs-Occasional Drinker
2.916600E-01
Weekly Drinker-vs-Social Drinker
3.726800E-01
Occasional Drinker-vs-Social Drinker
5.588200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.164800E-01
Normal-vs-Grade 2
7.486100E-02
Normal-vs-Grade 3
7.061600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.438630E-01
Grade 1-vs-Grade 3
1.161430E-01
Grade 1-vs-Grade 4
4.164800E-01
Grade 2-vs-Grade 3
5.895800E-01
Grade 2-vs-Grade 4
7.486100E-02
Grade 3-vs-Grade 4
7.061600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.711000E-01
Normal-vs-NonDiabetic
6.593800E-01
Diabetic-vs-NonDiabetic
2.522100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.944800E-01
Normal-vs-NoPancreatitis
7.006600E-01
Pancreatitis-vs-NoPancreatitis
1.505230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.543640E-01
Normal-vs-N1
6.467400E-01
N0-vs-N1
2.608800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.050200E-01
Normal-vs-TP53-NonMutant
2.760100E-02
TP53-Mutant-vs-TP53-NonMutant
2.527500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
